Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01351727 · ClinicalTrials.gov registry record
Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors
A clinical trial of Epileptic Seizures, sponsored by University of Arizona.
- Completed
- Registry status
- 97
- Enrollment target
- 1
- Study location
NCT01351727: Completed study of Epileptic Seizures, sponsored by University of Arizona.
NCT01351727 is a study of Epileptic Seizures that has completed, run by University of Arizona. The registered enrollment target is 97 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01351727, a study of Epileptic Seizures, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this proposed research is to identify individuals in southeastern Arizona aged 65 years and older who have new onset seizures (or newly diagnosed epilepsy) and monitor them for at least two years. In doing so the investigators will be able to describe the public health burden of this condition and to identify factors that predict clinical outcomes and health care needs in this population, using quantitative, administrative, and qualitative data. The aims of this proposed research are 1) to determine the two-year incidence of newly diagnosed epilepsy in the target population, 2) describe health care resource utilization of the target population using Medicare data, 3) validate the use of Medicare beneficiary data to estimate incidence of epilepsy, and 4) describe the burden of this condition in different ethnic groups.
Primary Outcome
A surveillance mechanism will be developed to identify and recruit seniors from emergency departments, neurology clinics, primary care clinics, and other service providers for seniors.
Conditions Studied
Study Locations (1)
Arizona
- Pima, Cochise, Santa Cruz Counties - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-09 |
What the finished NCT01351727 record still lists
NCT01351727 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target.
The record links to 1 condition, with Epileptic Seizures appearing as the primary indexed condition, and to 0 interventions.
NCT01351727 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT01351727 about?
NCT01351727 is a clinical study titled "Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors". The purpose of this proposed research is to identify individuals in southeastern Arizona aged 65 years and older who have new onset seizures (or newly diagnosed epilepsy) and monitor them for at least two years. In doing so the investigators will be able to describe the public health burden of this ...
What is the current status of trial NCT01351727?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2011-01. Estimated completion is 2014-09.
What conditions does trial NCT01351727 study?
This clinical trial studies the following conditions: Epileptic Seizures.
Who is sponsoring clinical trial NCT01351727?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01351727 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia